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Abstract
BACKGROUND: Depression in adults with type 2 diabetes can lead to non-adherence to selfmanagement behaviors and treatment recommendations, and ultimately worse health outcomes.
Currently, only 50% of adult patients with type 2 diabetes treated in the primary care setting are
screened for depression. Without screening for depression, a diagnosis of depression and
subsequent treatment is likely to be missed and the patient is more likely to experience worse
health outcomes and worse quality of life.
PURPOSE: The purpose of this study was to evaluate impact of provider education on improving
screening rates for depression in adult patients with type 2 diabetes within the primary care
setting. The objectives of this study were to: 1. Evaluate baseline assessment of screening rates
using the PHQ 2/9 by providers, and provider knowledge, facilitators, and barriers regarding
screening for depression in adult patients with type 2 diabetes in primary care;
2. Deliver an education intervention to providers on the importance of screening adult patients
with type 2 diabetes in the primary care setting.; and 3. Evaluate changes in depression screening
rates using the PHQ 2/9 post educational intervention.
METHODS: This study used a quasi- experimental design. Phase 1 consisted of an online
provider survey to assess knowledge, facilitators, and barriers in screening adult patients with
type 2 diabetes for depression. Phase 2 included a provider educational intervention with pre and
post chart reviews to assess depression screening rates.
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RESULTS: There was a significant increase in screening from 1.9% to 6.3% (p = .024) after the
educational intervention. Barriers to screening identified included time to screen, and knowledge
of documentation in the EHR.
CONCLUSION: Providers agree that screening for depression in adult patients with diabetes is
important and they feel comfortable with screening. Further work is needed to identify measures
that will continue to increase and sustain depression screening for adult patients with type 2
diabetes in the primary care setting.
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Introduction
Adult patients with type 2 diabetes are at an increased risk for depression related to the
cost of the disease, rapidly declining health, and non-adherence to treatment regimens (Badescu
et al., 2016). Only 50% of adult patients with type 2 diabetes seen in the primary care setting are
properly screened and identified for depression (Egede, Walker, Bishu, & Disbuke, 2016).
Moreover, studies have shown that adult patients with type 2 diabetes and unrecognized
depression have increased insulin resistance and have poorer adherence to treatment
recommendations (Ciechanowski, Katon, & Russo, 2000). The United States spends over $21.3
billion dollars annually in medical expenditures due to the impact of unrecognized comorbid
depression on adult patients with type 2 diabetes. This cost is associated with higher
complication rates, increased use of healthcare costs, and non-adherence to treatment plans,
which may have contributed to poor glycemic control (Egede et al., 2016). Adult patients with
type 2 diabetes are also predisposed to other comorbidities, such as stroke, kidney disease, and
death (Egede et al., 2016). Without properly screening adult patients with type 2 diabetes for
depression, there is likely to be an increase in non-adherence with diabetic treatment, which may
lead to further comorbidities and possible mortality (Badescu et al., 2016). Annual and periodic
screening with the patient health questionnaire 2–item (PHQ-2) or 9-item (PHQ-9) version
(PHQ-2/9) is an evidence-based strategy for addressing the problem of undiagnosed depression
in adult patients with type 2 diabetes in the primary care setting (Kroenke & Spritzer, 2001). This
brief screening tool is quick to implement (5 minutes or less), can be self-administered, has been
well received by primary care providers, and has been shown to increase identification for
depression, which can lead to better patient outcomes (Bajracharya, Summers, Amatya, &
Deblieck, 2016).
5
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Background
Depression is defined as a loss of pleasure in daily activities which can lead to fatigue,
weight loss, insomnia, psychomotor agitation, feelings of worthlessness, diminished ability to
concentrate, and possible suicide (American Psychiatric Association, 2013). Researchers have
found having depression can shorten one’s lifespan by 25-30 years compared to individuals who
do not suffer from depression (Voinov, Richie, & Bailey, 2013). Type 2 diabetes is defined as a
disease that occurs when an individual’s blood sugar is too high, and the body does not produce
enough insulin to counteract the process (National Institute of Diabetes and Digestive and
Kidney Disease, 2016). Globally, over 387 million people are affected by type 2 diabetes
(Bajracharya et al., 2016). More than 30 million Americans suffer from type 2 diabetes. In
Kentucky, it is estimated that over 14.5% of the adult population has been diagnosed with type 2
diabetes, and the treatment for these patients costs over $4.8 billion dollars annually (Bilous,
2013). According to the National Institute of Mental Health, it is estimated that 17.3 million
adults (7.1%) have been diagnosed with at least one major depressive episode (NIMH, 2017).
Studies have shown that when a patient has a chronic illness, they are 3 times more likely to have
co-morbid depression than the general population (Salinero-Fort et al., 2018).
Self- management is key in creating positive health outcomes for patients with type 2
diabetes. This often includes exercise, healthy diet, at home glucose monitoring, diabetes
management follow ups, and emotional wellbeing. However, self-management is often minimal
in adult patients with type 2 diabetes who suffer from comorbid depression, and this leads to
poor health outcomes and higher medical expenditures (Mut-Vitcu et al., 2016). Also,
depression rates in patients with type 2 diabetes are significantly higher in uncontrolled diabetes
6
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(30%), which can lead to poor self- care management (Mut-Vitcu et al., 2016). Studies have also
shown that the moment a type 2 diabetes diagnosis is made, many patients felt stressors related
to lifestyle changes that come with the disease, specifically diet changes and exercise (Kaltman
et al., 2015). The emotional demands that are attached to a type 2 diabetes diagnosis can worsen
depression, which in turn often contributes to difficulties with disease self- management
(Kaltman et al., 2015).
The U.S. Preventative Services Task Force recommends screening patients for depression
(B recommendation), especially in patients with chronic diseases such as type 2 diabetes
(USPSTF, 2009). In addition, the American Diabetes Association recommends screening adult
patients with type 2 diabetes during initial diagnosis of the disease, annual diabetic visits, when
complications arise, and during hospitalizations to assess psychosocial status (AACE, 2011).
However, despite these recommendations, depression screening in the primary care setting
occurs for less than 5% of adult patients with type 2 diabetes (Cantor, 2018).
A leading depression screening measure in primary care is the Patient Health
Questionnaire (PHQ; Kroenke & Spitzer, 2001). This screening tool is composed of the PHQ 2item and the PHQ 9-item. The PHQ-2, which is the initial screening, contains 2 questions to
help providers assess a patient’s mood over the last two weeks. If the PHQ-2 is found to be
positive, then the PHQ-9 is administered to further explore the severity of symptoms experienced
over the preceding two-week period (Arroll et al., 2010). The PHQ 2/9 is a brief selfadministered questionnaire that has been validated as a strong indicator for identifying
depression among adults in the primary care setting (Willborn et al., 2016). Administering the
PHQ-2/9 to adult patients with type 2 diabetes has been shown to improve physiological
7
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outcomes such as HBA1c levels, cholesterol levels, kidney function, and hypertension by
helping providers identify depression earlier and treat it concurrently. In addition, Willborn and
colleagues (2016) reported that the PHQ-2/9 showed an 88% sensitivity rate in identifying and
managing depression in adult patients with type 2 diabetes in the primary care setting. Given that
the PHQ 2/9 is a fast, reliable, inexpensive, easily adaptable evidenced-based screening tool, all
adult patients with type 2 diabetes should be screened in the primary care setting (Owens et al.,
2019). By utilizing the PHQ 2/9 for adult patients in primary care, type 2 diabetes and depression
can be treated concurrently, and this may prevent further comorbidities and mortality.
The PHQ 2/9 screening tool is located on the organization’s electronic health record (EHR)
where this study was performed as an accessible flow sheet, which can be easily added to the
patient encounter by a smart phrase. Unfortunately, there is no current protocol in place at this
primary care location to make sure screening with the PHQ 2/9 occurs in adult patients with type
2 diabetes, despite recommendations. If screenings occurred in the office prior to this study, they
were conducted in the following manner: 1. The provider would administer the PHQ 2/9 to the
patient through the (EHR during the patient visit, or ;2. The medical assistant (MA) would give a
paper copy to the patient to complete during rooming and the provider would discuss the results
during the visit and document the score in the EHR.

Purpose
The main purpose of this study was to evaluate the relationship between provider
education about the PHQ 2/9 and screening rates for depression in adults with type 2 diabetes in
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a primary care setting. An additional purpose was to gain an understanding of why depression
screenings were not being completed on adult patients with type 2 diabetes in this setting and
implement and evaluate an intervention to improve it.
The specific aims of the project were:
1. Describe a baseline assessment of depression screening rates using the PHQ 2/9 by providers,
and assess provider knowledge, facilitators, and barriers to screening for depression in adult
patients with type 2 diabetes in primary care.
2. Evaluate the impact of an educational intervention for providers on the importance of
screening adult patients with type 2 diabetes for depression, by comparing PHQ 2/9 screening
rates both pre- and post-intervention.
Methods
This project used a quasi-experimental study design to describe provider knowledge,
perceptions, and barriers related to depression screening and to evaluate depression screening
rates before and after an educational intervention for providers. This study consisted of three
phases.
Phase 1: Retrospective Chart review/Provider Survey
This phase included a retrospective chart review to assess baseline screening rates to
assess whether adult patients with type 2 diabetes were screened for depression using only the
PHQ 2/9. In addition, an anonymous electronic survey was sent to assess providers’ knowledge
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of the PHQ 2/9 questionnaire along with facilitators and barriers in screening adult patients with
type 2 diabetes for depression.
Phase 2: Provider Educational Intervention
This phase included an educational intervention for providers, delivered during a lunch
and learn session which also included sharing of phase 1 baseline screening rates and provider
survey results. Providers were also invited to share their on knowledge and perceived barriers
regarding screening.
Phase 3: Retrospective Chart Review
This phase included a post educational intervention retrospective chart review to
determine if screening rates increased using the PHQ 2/9 questionnaire for adult patients with
type 2 diabetes.
Theoretical Framework
The theoretical framework that informed the design of this study was Dorothea Orem’s
self-care nursing theory. The goal of Orem’s theory is to help create a strong patient provider
relationship, and for the patient to control or minimize the effects of poor chronic health by
understanding health deviation self-care requisites that can result from chronic illnesses such as
type 2 diabetes (Gonzalo, 2019). Since adult patients with type 2 diabetes are at an increased risk
for developing depression, providers need to be able to identify and treat depression for the
patient to achieve and/or maintain good mental and physical health. This will help the patient
adapt to pathologic changes that often occur with chronic illnesses such as type 2 diabetes.
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Setting
The setting for all phases of this study was an outpatient primary care office that is part of
a large healthcare organization in the Midwest. Annually, the office is responsible for the
management and treatment of approximately 4800 adult patients with type 2 diabetes in
Louisville, Kentucky and the surrounding area. At the time of this project, there were seven
providers in the office, which included two nurse practitioners and five physicians.
Sample
The medical record numbers for phases 1 and 3 of this study were obtained from the
healthcare organization’s data analytics team. A request was made to include eligible medical
records with the following inclusion/exclusion criteria. Inclusion criteria encompassed: 1.) Male
and female patients over the age of 18 presenting for annual wellness visits or diabetes
management visits; 2.) male and female patients with ICD-10 diagnosis of Type 2 Diabetes
Mellitus (E11.9) at the study site. Exclusion criteria included: 1.) All patients under the age of 18
years of age; 2.) patients with Type 1 or Gestational Diabetes; 3.) patients with single ICD-10
diagnosis of depression (F41.8); 4.) patients with the ICD-10 code of type II diabetes (E11.9)
along with other comorbidities (ex; hypertension, and hyperlipidemia); and 5.) patients not seen
at the chosen study site. Eligible medical records were then selected by the statistician by simple
random sampling and returned to the principal investigator (PI) for phases 1 and 3 of the study.
For the survey, the PI collected study site provider names from the organization’s HR
department. The survey (see Appendix B) included four yes or no, one Likert-style, and three
multiple choice questions that assessed providers’ perceptions of their knowledge of, and barriers
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to using the PHQ 2/9 in the clinical setting. The survey took approximately 5-10 minutes to
complete. The reliability and validity of the survey has not been determined, as it was generated
by the PI and not trialed prior to this study.
Procedures
This study occurred in three phases at one primary care office setting. Data were
collected to assess current screening rates and knowledge of providers who use the PHQ 2/9 in
adult patients with type 2 diabetes.
Phase 1: Retrospective chart review
For the retrospective chart review, 215 charts that met eligibility requirements were
audited from the study site, in order to determine baseline provider documentation of depression
screening using the PHQ 2/9 between July 1, 2018 and July 1, 2019. The results of the chart
review were provided in phase 2 during the educational intervention.
Regarding the provider survey, an email was sent to all seven providers at the study site
with a cover letter (see Appendix A) and link that would take them directly to a survey (see
Appendix B). The survey was given through an online service, REDCAP (Harris et al., 2019).
Participants were given a two-week window to complete the survey. The results of the survey
were anonymous and exported via Microsoft Excel through REDCAP; then they were analyzed
by a statistician.
The University of Kentucky Institutional Review Board granted approval (#46927) prior
to the start of the project. Permission was granted to obtain work email addresses for the specific
providers at the chosen site of study to send the cover letter (see Appendix A) and survey (see
12
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Appendix B). The cover letter explained the PI’s goals for the study and benefits to screening
patients with type 2 diabetes for depression. Responses to the survey were anonymous and data
collection was performed via REDCAP. The results from the survey were provided in phase 2
during the provider education intervention.
Phase 2: Education Intervention and Focus Group
The educational intervention was conducted two weeks after completion of the baseline
provider survey, on August 21, 2019. Topics included baseline screening rates and an aggregate
summary of survey responses. The intervention also focused on re-educating providers on how to
use the PHQ 2/9 questionnaire, why it is important to screen adult patients with type 2 diabetes
for depression, accessibility of the PHQ 2/9 in the EHR, and how to document the scores in the
EHR during the patient visit. The educational session lasted ten minutes. Education was given to
providers who were present that day using a PowerPoint presentation during a scheduled lunch
break where food was provided (see Appendix C). Permission was obtained prior to the
intervention for the primary investigator to attend a regularly scheduled provider meeting
following IRB approval. Providers who were unable to attend received a copy of the information
that was discussed during the presentation and were given the PI’s phone number in case
questions arose.
Providers who attended the educational session were asked to begin or continue utilizing
the PHQ 2/9 questionnaire for eligible patient visits. During the focus group meeting with
providers, a review of how to use the PHQ 2/9 questionnaire and where to document results in
the EHR was discussed. The importance of identifying depression earlier in adult patients with
type 2 diabetes by using the PHQ 2/9 was also discussed. Results from the Phase 1 chart review
13
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and survey were reviewed with providers. Providers were given the opportunity to discuss
barriers to screening eligible adult patients with type 2 diabetes using the PHQ 2/9 questionnaire.
The PI took notes during the conversation.
Phase 3: Retrospective Chart Review
Phase three consisted of a retrospective chart review that occurred four weeks post
educational intervention (08/21/2019-09/21/2019) to determine if depression screening rates
increased in adult patients with type 2 diabetes. The data analytics team from the healthcare
organization helped to compile a list of eligible charts that met the inclusion and exclusion
criteria and 215 charts were reviewed. All seven providers were included in the post education
audit chart review since four of the providers were present for the educational intervention, and
the other three received a copy of the PowerPoint slides (see Appendix C) for review. Audit tools
were used in both chart reviews to ensure consistency, then destroyed per guidelines.
Data Analysis
Descriptive statistics were used to summarize the variables such as age, gender, ethnicity,
insurance use, PHQ 2/9 results, and the provider survey responses using Microsoft Excel to
create tables with percentages. Screening rates for using the PHQ 2/9 questionnaire were also
examined pre and post educational intervention using the chi-square test of association using
SPSS, version 25, with an alpha of <.05. Focus group responses were written down by the PI
and categorized into themes.
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Results
PHASE 1: BASELINE CHART REVIEW
Patients on average were Caucasian (94%, n=202) females (53%, n=114) over the age of
65 (47%, n=101) and had Medicare insurance (46%, n=100; see Table 2). The data research
query returned over 26,317 eligible medical records and 215 charts were randomly selected by
choosing every fifth one until a sufficient sample size was obtained. The charts were reviewed to
determine if providers were screening adult patients with type 2 diabetes for depression using the
PHQ 2/9 questionnaire. For the score to be counted in the audit, the PHQ 2/9 questionnaire score
needed to be visible in the patient’s visit encounter summary. Of the 215 randomly selected
charts, only four (1.9% see table 1) were found to have been screened with the PHQ 2. Patients
who were identified as being positive for screening were on average Caucasian (100%, n=4)
males (50%, n=2) and females (50%, n=2) over the age of 65 (75%, n=3) with Medicare
insurance (75%, n=3; see table 3). Of the four patients that were screened, three were found to be
negative for depressive symptoms and one was found to be positive.
PHASE 1: PROVIDER SURVEY
The provider survey (see Appendix B) assessing knowledge, facilitators and barriers to
using the PHQ 2/9 was sent to seven providers at one primary care office. Out of the seven
providers, four returned their responses anonymously through REDCAP (see Table 4). Providers
stated they were familiar with the PHQ, mostly familiar with wear to access and document in the
EHR, they sometimes screen patients, agree that it is important to screen, they feel confident in
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screening with a comfort level mean of 8.3, but time was their biggest barrier in screening
patients.

PHASE 2: FOCUS GROUP RESULTS
After the education was presented, providers were afforded the opportunity to share their
feedback regarding the PHQ 2/9 questionnaire. Four providers were present and identified time
as the biggest barrier in performing the PHQ 2/9 for adult patients with type 2 diabetes. The
providers stated they were knowledgeable and confident in screening but were overwhelmed
with high patient loads, which they felt contributed to missed screenings. Since responses to the
provider survey were anonymous for phase 1, there was no way to identify whether the providers
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who attended the focus group were the same ones that filled out the provider survey. There was
no mention of lack of knowledge as a barrier during the focus group.
PHASE 3: RETROSPECTIVE CHART REVEW
Patients included in the post-intervention chart audit were most likely to be Caucasian
(85%, n=149) males (50.3%, n=88) between the ages of 55-65 (36%, n=63) with private
insurance (61%, n=107; see table 5). The second data research query returned over 2,154 eligible
medical records that met criteria for the retrospective chart review post education intervention
for phase 3 (see Appendix C). There were 175 medical records chosen randomly by picking
every 5th one until a sufficient sample size was obtained. The charts were reviewed to determine
if providers were screening adult patients with type 2 diabetes for depression using the PHQ 2/9
questionnaire. For the score to be counted in the audit, the PHQ 2/9 questionnaire score needed
to be visible in the patient’s visit encounter summary. Patients who were identified as being
positive for screening on average were Caucasian (73%, n=8) females (82%, n=9) ages 55-65
(46%, n=5), and had private insurance (73%, n=8; see table 6). Of the 175 charts reviewed, 11
patients (6.3%; see Table 1) were screened using the PHQ. Of the 11 patients that were screened,
six patients were found to be negative for depression using the PHQ 2, and five were positive
and then followed up with the PHQ 9 to determine the severity of depressive symptoms.
After the educational intervention, providers were more likely to agree that screening is
important and to feel comfortable screening with the PHQ 2/9 questionnaire (mean score 8.3; see
Table 4). There was a significant increase in screening from 1.9% to 6.3% (p = .024; see Table 1)
after the educational intervention. Barriers to screening included time, which was consistent with
the main barrier identified in phase 1.
17
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Discussion
The purpose of this study was to describe a baseline assessment of depression screening
rates using the PHQ 2/9, and assess provider knowledge, facilitators, and barriers to screening
for depression in adult patients with type 2 diabetes in a specific primary care clinic. Second, to
evaluate the impact of an education intervention for providers on the importance of screening
adult patients with type 2 diabetes for depression in the primary care setting. Depression
screening rates increased from 1.9% to 6.3% (see Table 1), and time was identified as the most
significant barrier to screening both pre and post intervention. The finding of low screening rates
is consistent with the national average of 5% (Cantor, 2018), but it is encouraging that this clinic
increased screening rates from 1.9% to 6.3% (see Table 1), which now exceeds the national
average. However, 6.3% is still very low and additional strategies to improve depression
screening rates are still very much needed, both in this setting and nationally.
The provider participants in this study all had good baseline knowledge scores and
positive perceptions about the importance of screening for depression in adults with type 2
diabetes, which suggests that they are willing and able to complete the depression screening.
However, time to screen appears to be a significant barrier that needs to be addressed for the
providers in this setting. This is also a national problem, as evidenced by the fact that other
researchers have also found time to be the biggest barrier to screening (Colligan et al, 2018;
Sanchez, Eghaneyan, & Trivedi, 2016). Thus, an important finding from this study is the
recognition of time as a major barrier that needs to be addressed in this setting.
There are a variety of evidence-based strategies that have helped improve depression
screening rates in primary care settings and the use of information technology (IT) is a leading
18
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approach. Use of IT to facilitate depression screening in the primary care setting where this study
took place would be particularly helpful, as it addresses the barrier of time, provides a
standardized place to document, and initiates provider alerts (Savoy & O'Gurek, 2016; Triveti et
al., 2019). Other evidence-based strategies include empowerment of staff, which includes having
the medical assistant (MA) provide a paper copy of the PHQ for the patient to complete while .
This will decrease the time it takes to screen for providers and staff and give the patient
something to do while waiting to see the provider. Patients with access to their patient portal
could be asked to complete the questionnaire electronically prior to their visit (Savoy &
O’Gurek, 2016; Triveti et al., 2019).
These are strategies to consider implementing in this setting as a next step. The increase
in screening rates after the provider education suggests that this session may have led to the
increase in depression screening. Although this study was not designed to test for causation, it is
encouraging that there was a significant improvement in screening after a brief and simple
session with the providers. Because baseline knowledge scores were already high and
perceptions started out positive, it does not seem likely that the providers learned new
information; however, it is possible that simply discussing depression screening brought it to the
forefront of their attention and thus made them more likely to screen. In addition, providers were
very engaged during the focus group when reminded of how to document via smart text phrase in
the EHR. Further investigation is needed to determine what specific element of the educational
intervention led to this improvement. Brief education to providers may have played a major role
with the increased screening rates. Studies have shown that efforts such as education to
providers, consistent depression management and follow up, and a collaborative care approach
19
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can increase depression screening rates in the primary care setting (Maimone & Marhatta, 2015;
Unützer & Park, 2012). Further research to assess depression screening for all adults in the
same age group would lend attention to the need for screening.
The increase in depression screening rates is a positive and encouraging finding from this
study; however, the screening rates are still very low and evidence-based strategies to sustain this
improvement and improve screening even more are needed. Effective sustainment strategies that
have worked well in other settings and would be appropriate in this study’s setting include the
use of performance metrics and reporting mechanisms (Schaeffer & Jolles, 2019; Kroenke &
Unutzer, 2017). This can often include strategies such as the use of scorecards or monthly
provider audits by an appointed team leader in the clinic.
Implications for Practice
Time was identified by the providers as the biggest barrier to screening, so implementing
strategies to reduce the time burden is an important next step for this clinic as well as other
clinics. An evidence-based strategy that should be considered for practice is training and
empowerment of staff to help streamline the process (Savoy & O’Gurek, 2016). Since one
provider in the baseline chart audit screened a patient positive using the PHQ 2 but did not
follow up with the PHQ 9 per recommendations, further training needs to occur with providers.
Future practice should include continued education for providers on the importance of screening
adult patients with type 2 diabetes for depression using the PHQ 2/9 (Maimone &Marhatta,
2015; Unützer & Park, 2012). One way to remind providers how the screening process with the
PHQ2/9 works is to place posters and prompts in the office rooms (Schaeffer, & Jolles, 2019).
Another beneficial method would be for the MA to give the patient a paper copy of the PHQ 2/9
20
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screening tool to complete while rooming, then place scores in the EHR for the provider to
discuss with the patient. This is an efficient use of time and a collaborative approach that does
not overburden the patient, provider or staff (Savoy & O’Gurek, 2016).
If the EHR has the capability, it would be ideal to initiate a best practice advisory alert for
all adult patients with type 2 diabetes to ensure they are screened during annual visits and follow
ups (Savoy & O'Gurek, 2016; Kroenke, 2017). Additionally, for patients with access to the
patient portal, another implication for future practice would be the use of Mychart, which
provides access to their medical records and already in use within the organization. This could
serve as a means for the patient to fill out the PHQ 2/9 questionnaire prior to the scheduled visit.
This allows the provider to already have the scores in the EHR to discuss during the patient
encounter. The responses would be available on the vital sign screen and the provider can carry
over the results into the patient encounter summary (Savoy & O’Gurek, 2016; Triveti et
al.,2019).
It would also be worthwhile to implement a tracking measure to monitor screening
adherence (Kroenke & Unutzer, 2017). According to a prediction made by the World Health
Organization, by the year 2030 depression rates will double and be the leading cause of life lost
due to disability (El-Hechmi et al., 2013). It is imperative for primary care offices to ensure that
they screen all adult patients with type 2 diabetes for depression along with proper follow up and
management, to help ensure the patient is being treated both mentally and physically.
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Limitations
Limitations of this study included a small sample size of providers who responded to the
survey (N=4) out of a total of seven possible. In addition, only four out of a total of seven
providers attended the focus group. Since the surveys were anonymous, there was no way to
determine if the providers that attended the focus group (N=4)were the same providers that
responded to the survey (N=4). In addition, this study took place at only one clinic over a period
of a few months. Increasing the study reach to include multiple locations could increase the
number of providers who participate in the survey. The post chart review audit may have been
higher if multiple sites were included.
Conclusion
Patients with diabetes are 30% more likely to be depressed than the general population
(Mut-Vitcu et al., 2016), and depression leads to worse self-management and health outcomes.
However, depression screening rates among adults with diabetes are very low, at only 5%.
Because of the impact on health outcomes and quality of life, providers must do a better job of
screening in order to identify and treat depression appropriately. The PHQ 2/9 is a brief, selfadministered questionnaire that has been validated for identifying depression among adults in the
primary care setting (Kroenke & Spritzer, 2001). Patients may only see their primary care
provider every 3-6 months, so screening at these visits is important so depression can be
identified and addressed if indicated; ;otherwise, the negative effects are likely to continue as the
patient goes untreated. Earlier identification of depression can lead to better diabetes
management, improve morbidity and mortality and help lower medical expenditures when
patients are treated for type 2 diabetes and depression concurrently. In this study, after a brief
22
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education session for providers that focused on why and how to screen and where to document
the screening, there was an increase in depression screening rates for adult patients with type 2
diabetes. However, screening rates were still low and there remains much need for improvement.
Future work should seek to identify which specific elements of this intervention contributed to
the success and strategies to ensure sustainability of these improvements should be explored.
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Table 1. Screening rates for Depression

Screened
Not Screened

Pre- education
n (%)

Post-education
n (%)

4 (1.9%)
211 (98.1%)
215

11 (6.3%)
164 (93.7%)
175

Table 2. Pre education chart review Demographics (N=215)
Gender
Male
Female
Age
18-24
25-34
35-44
45-54
55-65
>65
Race
Caucasian
African American
Hispanic
Asian
Insurance
Private
Medicare
Medicaid

101
114

47%
53%

0
3
14
35
62
101

0%
1%
7%
16%
29%
47%

202
11
1
1

94%
5%
.5%
.5%

96
100
19

45%
46%
9%

24
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Table 3. Phase 1 chart review results demographics (N=4)
Gender
Male
Female
Age
18-24
25-34
35-44
45-54
55-65
>65
Race
Caucasian
African American
Hispanic
Asian
Insurance
Private
Medicare
Medicaid

2
2

50%
50%

0
0
1
0
0
3

0%
0%
25%
0%
0%
75%

4
0
0
0

100%
0%
0%
0%

1
3
0

25%
75%
0%

Table 4.
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Table 5. Post education chart review Demographics (N=175)
Gender
Male
Female
Age
18-24
25-34
35-44
45-54
55-65
>65
Race
Caucasian
African American
Hispanic
Asian
Insurance
Private
Medicare
Medicaid

88
87

50.3%
49.7%

0
4
10
42
63
56

0%
2%
6%
24%
36%
32%

149
21
0
5

85%
12%
0%
3%

107
56
12

61%
32%
7%

Table 6. Post education chart review results demographics (N=11)
Gender
Male
Female
Age
18-24
25-34
35-44
45-54
55-65
>65
Race
Caucasian
African American
Hispanic
Asian
Insurance
Private
Medicare
Medicaid

2
9

18%
82%

0
1
1
4
5
0

0%
9%
9%
36%
46%
0%

8
3
0
0

73%
27%
0%
0%

8
0
3

73%
0%
27%
26
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Appendix A
Dear Providers at chosen site of study,
You are being invited to participate in a research study, “Evaluation of Depression Screening by
Primary care providers who provide care for Adult Patients with Type II Diabetes Mellitus”.
The purpose of this study will be to assess baseline screening rates in providers who screen for
depression in the adult type II diabetic population. Furthermore, the purpose will be to educate
providers about the benefits of identifying depression using the PHQ 2/9 screening tool and
treating it concurrently with type II diabetes. The focus group for this study will be providers and
those who treat adult patients with type II Diabetes Mellitus in the primary care setting.
The Principal Investigator is Kristy Bryant who is a student in the Doctor of Nursing Practice
Program at the University of Kentucky College of Nursing and current employee at the chosen
site of study.
Your participation in this study is entirely voluntary. If you agree to participate in the study, you
will be asked to complete an online survey on REDCAP that asks you to provide answers to 8
questions, in the form of YES or NO, Likert Scale, and multiple choice. The survey should only
take 5-10 minutes to complete.
An educational session will follow 1-2 weeks after completion of the survey in phase 2 of this
study. Education will be provided on the importance of utilizing the PHQ 2/9 screening tool,
where to find and document the tool in EPIC, and why we need to screen Type II Diabetics for
depression. The educational session will also include survey results to discuss knowledge,
facilitators and barriers to using the PHQ 2/9 screening tool in the primary care setting. The
study will take place from May 1, 2019 to October 1, 2019. There is no risk to participate in the
study.
The benefits that may be derived from this research include; that with future improvement of
depression screening in adults with type II diabetes mellitus, individuals who have not been
previously recognized or screened for depression will be identified as screening process
improvement takes place. Earlier identification of depression in chronic diseases such as type II
Diabetes Mellitus is associated with decreased comorbidities and mortality associated with the
disease, decreased health care expenditures, and improved quality of life.
We make every effort to safeguard your data once received on our servers via REDCAP. Given
the nature of online surveys, as with anything involving the internet, we can never guarantee the
confidentiality of data still en route to us. REDCAP is a secure, web-based application designed
exclusively to support data capture for research studies. Your responses will be anonymous.
Records of your participation in this study will be kept confidential to the extent permitted by
law. Results of this research will be reported as summarized data and will not contain any
identifiable individual data.
Should you have any questions you may contact Kristy Bryant, the Principal Investigator, at
kmbu253@uky.edu. If you have complaints, suggestions, or questions about your rights as a
research volunteer, contact the staff in the University of Kentucky Office of Research Integrity at
859-257-9428 or toll-free at 1-866-400-9428.Your completion of the survey will be considered
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your consent to participate in the study and as your agreement that you have been sufficiently
informed of the purpose of the study and any risks and benefits. If you agree to participate in the
study, please click on the below link to access the survey.
https://redcap.uky.edu/redcap/surveys/?s=E3TPEDHTJJ
Thank you in advance for your assistance with this important project.
Sincerely,
Kristy Bryant College of Nursing, University of Kentucky
DNP Student
E-MAIL: kmbu253@uky.edu
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Appendix B

Evaluation of Depression Screening by Providers for Adult Patients with type II diabetes mellitus

1)

Are you familiar with the PHQ 2/9 screening
tool for Depression?
Yes
No

2)

Do you know where to access the PHQ 2/9
screening tool to administer to your patients?
Yes
No

3)

Do you know where to document the PHQ 2/9
screening scores in EPIC?
Yes
No

4)

How often do you use the PHQ 2/9 screening
tool on your Type II Diabetic patients

5)

Do you feel that it is important to screen adults
with Type II Diabetes for Depression?

6)

Do you feel confident in scoring patients using
the PHQ 2/9 screening tool?
Yes
No

7)

8)

On a scale of 1-10 (with 1 being not comfortable
at all and 10 being completely comfortable),
how do you rate your comfort level in using the
PHQ 2/9 in screening patients for depression?
What barriers do you feel prevent you from
performing the PHQ 2/9 screening for
depression on your adult patients with type II
diabetes? Fill in the blank
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of PHQ

6

7

1

8

Time

2

9

3

4

10

Importance

Knowledge of PHQ

Other

DEPRESSION SCREENING FOR ADULTS WITH TYPE 2 DIABETES

Appendix C
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